Comments
Loading...
Carmell (NASDAQ:CTCX) Stock Quotes, Forecast and News Summary
Carmell Stock (NASDAQ: CTCX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Carmell (CTCX) stock?
You can purchase shares of Carmell (NASDAQ:CTCX) through any online brokerage.
Who are Carmell (CTCX) competitors?
Other companies in Carmell’s space includes: Vincerx Pharma (NASDAQ:VINC), Immuron (NASDAQ:IMRN), T2 Biosystems (NASDAQ:TTOO), Can Fite Biofarma (AMEX:CANF) and BioRestorative Therapies (NASDAQ:BRTX).
What is the forecast, or price target, for Carmell (CTCX) stock?
There is no analysis for Carmell to provide a consensus price target.
What is the current price for Carmell (CTCX)?
The stock price for Carmell (NASDAQ: CTCX) is $0.404 last updated January 8, 2025 at 12:29 PM EST.
Does Carmell (CTCX) pay a dividend?
There are no upcoming dividends for Carmell.
When is Carmell (NASDAQ:CTCX) reporting earnings?
Carmell’s Q4 earnings are confirmed for Monday, March 31, 2025.
Is Carmell (CTCX) going to split?
There is no upcoming split for Carmell.
What sector and industry does Carmell (CTCX) operate in?
Carmell is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.